2 common drugs may offer short-term improvements in long-COVID-related fatigue
A recent large clinical trial published in The Lancet Infectious Diseases explored the effectiveness of common medications in alleviating fatigue associated with long COVID. The study, involving nearly 800 adults treated at specialized long-COVID clinics in England, compared the impact of three drugs—colchicine (an anti-inflammatory), a combination of famotidine and loratadine (antihistamines), and rivaroxaban (a … Read more